Illness	Number of cases
Multiple myeloma and malignant plasma cell neoplasms - Multiple myeloma not having achieved remission (C90.00)	145
Non-follicular lymphoma (C83.3)	91
Plasmodium falciparum malaria - Plasmodium falciparum malaria unspecified (B50.9)	48
Lymphoid leukaemia - Acute lymphoblastic leukemia not having achieved remission (C91.00)	46
Malignant neoplasm of bronchus and lung (C34.1)	45
Lymphoid leukaemia - Chronic lymphocytic leukemia of B-cell type not having achieved remission (C91.10)	44
Myeloid leukaemia - Acute myeloblastic leukemia not having achieved remission (C92.00)	39
Viral pneumonia not elsewhere classified (J12.8)	37
Non-follicular lymphoma (C83.1)	30
Pneumonia organism unspecified - Pneumonia unspecified organism (J18.9)	28

Top 10 treatments

Treatment	Number
Others therapeutic procedures to influence the immune system (8-547.0)	1.113
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.11)	678
(6-007.72)	237
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.12)	235
Transfusion of blood, red blood cells or platelets from a donor to a recipient (8-800.c0)	218
Taking a tissue sample (biopsy) of the bone marrow without surgical incision (1-424)	188
(9-984.7)	137
Cancer treatment for several days (e.g. 5-8 days) with two or more chemotherapy drugs administered into a vein (8-544)	124
Comprehensive examination of blood cancer (1-941.0)	106
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.21)	100

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0500 , 3752 , 0152

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ05
CQ02

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
181	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
132	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
128	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Lectureships / teaching posts at universities of applied sciences
Lectureships / teaching posts at colleges and universities
Participation in multi-centre phase III/IV studies
Project-related cooperation with colleges and universities
Editors of scientific journals/textbooks
Doctoral supervision
Student training (clinical traineeship / internship year)
Participation in multi-centre Phase I/II studies

Training

No.	Training in other healing professions	Comment
HB19	Nursing professionals	384 Plätze
HB17	Auxiliary nurse (m/f)	Wir bilden Pflegefachhelfer*innen aus (50 Plätze).
HB15	Anaesthesia technical assistant (m/f)	96 Plätze OTA und ATA
HB07	Surgical technical assistant (m/f)	96 Plätze OTA und ATA
HB20	Nursing professional B. Sc.	In Kooperation mit Münchner Hochschulen